Click here to read the July/August 2013 magazine of Pharmaceutical Outsourcing.Pauwels Consulting was recently contacted by Pharmaceutical Outsourcing, the Journal of Pharmaceutical and Biopharmaceutical Contract Services, to share our thoughts on implementing a risk mitigation approach for identifying and classifying modes of transport according to EU GDP.

Pharmaceutical Outsourcing is a specialist journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, Pharmaceutical Outsourcing brings a wide coverage of trends and issues in the industry.

As one of our subject matter experts on EU GDP and temperature-controlled storage, transport and distribution, Luc Huybreghts shared his thoughts on the new trends in the EU GDP, the most important changes versus the draft version of July 15, 2011, and a risk mitigation approach to safely identify and classify modes of transport according to the new EU GDP.

The article below was published in the July/August 2013 edition of Pharmaceutical Outsourcing. For more information regarding the content of the article, please contact Luc Huybreghts, Senior Consultant Pharmaceutical Services at Pauwels Consulting. For more information regarding our Pharma and Biotech services, please contact Christophe Van Bael, marketing manager at Pauwels Consulting.

Risk Mitigation according to EU GDP - 1 of 3

Picture 1 of 3

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *